Belapectin

N/A

Report date: 2025/12/16 20:00:07
NME

Base Information

Drug NameBelapectin
Drug Alias NameGalactoarabino-rhamnogalaturonateGR-MD-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsPsoriasisLiver CirrhosisHypertension, Portal +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGalectin Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGalectin Therapeutics Inc
Inactive CompaniesEarle A. Chiles Research Institute
Active IndicationsHepatic InsufficiencyCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck +[4] 
Inactive IndicationsPsoriasisLiver CirrhosisHypertension, Portal +[5] 

Other Information

ATC CodeN/A
Related LinksN/A